Ocuphire Pharma Inc (NASDAQ:OCUP)
| 3.69 Delayed Data As of Mar 24 |  +0.09 / +2.50%Today’s Change | 1.78 Today|||52-Week Range 4.43 | +4.53% Year-to-Date |
Latest OCUP News | Press Releases
No recent news for Ocuphire Pharma Inc.
Today’s Trading
| Previous close | 3.60 |
| Today’s open | 3.57 |
| Day’s range | 3.57 - 3.69 |
| Volume | 966 |
| Average volume (3 months) | 130,421 |
| Market cap | $79.7M |
Data as of 3:59pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | +27.74% |
| Earnings growth (this year) | +117.47% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 94.06 |
| Price/Book | 3.25 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| THTXTheratechnologies In... | 0.00 | 0.00% |
| EYPTEyePoint Pharmaceuti... | -0.04 | -1.72% |
| ---- | ||
| SPROSpero Therapeutics I... | +0.04 | +2.92% |
Data as of 3:59pm ET, 03/24/2023
Financials
| Next reporting date | March 27, 2023 |
| EPS forecast (this quarter) | $1.32 |
| Annual revenue (last year) | $589.0K |
| Annual profit (last year) | -$56.7M |
| Net profit margin | -9,625.30% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Farmington Hills, Michigan |
Forecasts
